NVOS Novo Integrated Sciences Corp Gross Return on Sales

Official company branding of Novo Integrated (NVOS)

The speculative potential of creating a diversified medical holding is driving the price action of Novo Integrated Sciences (NVOS), which is further supported by the gross margin trend. The 0.00 mark indicates a yield level based on the provision of primary care and rehabilitation. Meanwhile, the stability of operating metrics is ensured by the efficient distribution of wellness products through regional warehouses, eliminating product shortages in clinics.

Novo Integrated (NVOS) - Gross Margin from 07/04/2022 to 11/16/2024

Analytical breakdowns and data insights for company Novo Integrated Sciences (NVOS)

- current quotes and average value forecast:
Fundamental valuation:Novo Integrated Sciences
Original product of Novo Integrated Sciences Corp

The business model of Novo Integrated Sciences (NVOS) depends on the cost of hiring medical personnel while maintaining a stable administrative core. The gross margin quantifies this efficiency by subtracting direct production costs from total revenue to determine the profit share per unit of service. Analyzing the gross profit margin allows an investor to strip away management's accounting maneuvers and assess the real value of assets regardless of the debt load.

Key competitors

HCA Holdings (HCA) - Gross Margin|THC (tenethealth.com) - Gross Margin|Gross Margin Fresenius Medical|Return on Gross Profit SOLV (Solventum Health)|Return on Sales by Gross Profit Encompass Health Corporation|Universal Health Services - Return on Gross Profit|DVA - Return on Gross Profit|RadNet Management - Gross Margin|Gross Profit Rate OPCH (Option Care Health Inc)|Surgery Partners, Inc. (SGRY) - Gross Profitability|Return on Gross Profit Premier|EYE (National Vision Holdings, Inc.) - Gross Margin|Progyny Inc (PGNY) - Return on Sales by Gross Profit|Gross Margin ARDT|Gross Profitability SEM (Select Medical Inc.)|Gross Margin ASTH (Astrana Health, Inc.)|Gross Margin Pediatrix Corp MD|USPH: Return on Gross Profit|Gross Profit Margin Pennant Group Inc|organogenesis.com (ORGO) - Gross Profitability|Return on Gross Profit Nutex Health Inc.|Gross Profitability aunainvestors.com|SBC: Gross Profit Rate|Gross Margin EOLS|CYH - Gross Profit Margin|Gross Profitability The Beauty Health Company SKIN|Gross Profit Ratio MDWD (MediWound Ltd.)|BTMD: Return on Gross Profit|thejoint.com - Gross Profit Ratio|DCGO: Gross Margin|P3 Health Partners Inc. (PIII) - Gross Margin|Return on Gross Profit GANX|Gross Profit Margin EUDA Health Holdings EUDA|Gross Profitability Basel Medical Group Ltd (BMGL)|Return on Sales by Gross Profit CollPlant Biotechnologies Ltd.|Cuprina Holdings - Return on Gross Profit|CCM - Return on Gross Profit|AMS - Gross Profitability|MEDIROM Corp (MRM) - Return on Gross Profit|Avalon GloboCare Corporation (ALBT) - Gross Profitability|Gross Profit Margin DIH Holding US, Inc. (DHAI)|XAGE (carmellcosmetics.com) - Gross Margin|NewGenIvf Group Ltd - Gross Profitability Margin|Gross Margin ATIP|CMAX (CareMax Medical Group) - Gross Profit Rate|Gross Margin KDLY (kindlymd.com)|ModivCare Inc. (MODV) - Gross Profit Margin|SSY - Gross Profitability|BACK (IMAC Regeneration Centers) - Gross Return on Sales